EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies

Qin Guo, Jiao Jia, Xiao Li Sun, Hong Yang, Yan Ren

Frontiers in Psychiatry · 08.01.2024 · 14

DOI: 10.3389/fpsyt.2023.1319870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 08.01.2024. Verfasst von Qin Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, Shanxi, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study identified the metabolic biomarkers for different clinical phases of bipolar disorder (BD) through metabolomics. BD patients were divided into three groups: patients with BD and depressive episodes (BE, n = 59), patients with BD and mania/hypomania episodes (BH, n = 16), patients with BD and mixed episodes (BM, n = 10), and healthy controls (HC, n = 10). Serum from participants was collected for metabolomic sequencing, biomarkers from each group were screened separately by partial least squares analysis, and metabolic pathways connected to the biomarkers were identified. Compared with the controls, 3-D-hydroxyacetic acid and N-acetyl-glycoprotein showed significant differences in the BE, BH, and BM groups. This study suggests that different clinical types of BD share the same metabolic pathways, such as pyruvate, glycolysis/gluconeogenesis, and ketone body metabolisms. In particular, abnormal glycine, serine, and threonine metabolism was specific to BM; β-glucose, glycerol, lipids, lactate, and acetoacetate metabolites were specific to depressive episodes; the guanidine acetic acid metabolites specific to BH; and the acetic and ascorbic acids were metabolites specific to manic and BM. We screened potential biomarkers for different clinical phases of BD, which aids in BD typing and provides a theoretical basis for exploring the molecular mechanisms of BD.

Schlagwörter

Stichwörter der Autor:innen

1H nuclear magnetic resonance technologydepressive episodesguanidine acetic acidhypomania episodesmixed episodestrimethylamine oxide

Autor:innen und Institutionen

  • Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Mental Health, Shanxi Bethune Hospital, Taiyuan, China.

Zitieren

APA

Guo, Q., Jia, J., Sun, X. L., Yang, H., & Ren, Y. (2024). Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1319870

Vancouver

Guo Q, Jia J, Sun XL, Yang H, Ren Y. Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies. Frontiers in Psychiatry. 2024;14. doi:10.3389/fpsyt.2023.1319870

BibTeX
@article{Guo2024,
  author = {Guo, Qin and Jia, Jiao and Sun, Xiao Li and Yang, Hong and Ren, Yan},
  title = {Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies},
  journal = {Frontiers in Psychiatry},
  year = {2024},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1319870}
}
Kostenlos starten →